Cardiol Therapeutics Inc. (CRDL) is looking to harness the proven anti-inflammatory properties of cannabidiol (CBD) to help reverse deadly inflammatory processes that occur in heart disease with its flagship drug, CardiolRx...
Editor’s Note: At the National Institute for Cannabis Investors we’re always looking out for special opportunities we believe you, as a valued subscriber, will want to see and in this case hear. Our advisory board member, Michael Robinson has debuted...
